NO125776B - - Google Patents

Download PDF

Info

Publication number
NO125776B
NO125776B NO170199A NO17019967A NO125776B NO 125776 B NO125776 B NO 125776B NO 170199 A NO170199 A NO 170199A NO 17019967 A NO17019967 A NO 17019967A NO 125776 B NO125776 B NO 125776B
Authority
NO
Norway
Prior art keywords
rabbit kidney
vaccine
rubella virus
rubella
virus
Prior art date
Application number
NO170199A
Other languages
English (en)
Norwegian (no)
Inventor
C Huygelen
J Peetermans
Original Assignee
Rit Rech Ind Therapeut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10444820&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO125776(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Rit Rech Ind Therapeut filed Critical Rit Rech Ind Therapeut
Publication of NO125776B publication Critical patent/NO125776B/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/20—Rubella virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/36011—Togaviridae
    • C12N2770/36211—Rubivirus, e.g. rubella virus
    • C12N2770/36234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO170199A 1966-10-21 1967-10-19 NO125776B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB47399/66A GB1135987A (en) 1966-10-21 1966-10-21 Attenuated live rubella virus vaccine and method of production

Publications (1)

Publication Number Publication Date
NO125776B true NO125776B (de) 1972-10-30

Family

ID=10444820

Family Applications (1)

Application Number Title Priority Date Filing Date
NO170199A NO125776B (de) 1966-10-21 1967-10-19

Country Status (19)

Country Link
US (1) US3686394A (de)
AT (1) AT279038B (de)
BE (1) BE705342A (de)
BR (1) BR6794003D0 (de)
CA (1) CA956232A (de)
CH (1) CH477553A (de)
CY (1) CY635A (de)
DE (1) DE1617775B1 (de)
DK (1) DK121619B (de)
ES (1) ES345972A1 (de)
FI (1) FI43625B (de)
FR (2) FR7321M (de)
GB (1) GB1135987A (de)
IL (1) IL28696A (de)
LU (1) LU54664A1 (de)
NL (1) NL148799B (de)
NO (1) NO125776B (de)
SE (1) SE341451B (de)
YU (1) YU31804B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2129777C3 (de) * 1971-06-16 1982-04-15 Takeda Chemical Industries, Ltd., Osaka Verfahren zur Herstellung eines stark ageschwächte Rötelviren enthaltenden Impfstoffes
FR2505657A1 (fr) * 1981-05-13 1982-11-19 Pasteur Institut Perfectionnements apportes aux agents de stabilisation de virus vivants pour la preparation de vaccins, et vaccins stabilises contenant lesdits agents de stabilisation
RU2213776C2 (ru) * 2001-11-20 2003-10-10 Унитарное государственное московское предприятие по производству бактерийных препаратов Минздрава РФ Способ получения адаптированного к фибробластам эмбрионов перепела вируса краснухи
US8460680B2 (en) * 2009-04-24 2013-06-11 National Health Research Institutes Polyvalent chimeric rubella virus-based vaccines

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3401084A (en) * 1965-07-29 1968-09-10 Merck & Co Inc Rubella vaccine and its preparation

Also Published As

Publication number Publication date
CH477553A (fr) 1969-08-31
US3686394A (en) 1972-08-22
CA956232A (en) 1974-10-15
IL28696A (en) 1971-12-29
GB1135987A (en) 1968-12-11
LU54664A1 (de) 1967-12-12
FR7321M (de) 1969-10-06
SE341451B (de) 1971-12-27
YU203467A (en) 1973-06-30
BE705342A (de) 1968-03-01
FR1548489A (de) 1968-12-06
AT279038B (de) 1970-02-25
CY635A (en) 1972-03-07
YU31804B (en) 1973-12-31
BR6794003D0 (pt) 1973-02-22
ES345972A1 (es) 1968-12-01
NL148799B (nl) 1976-03-15
NL6714223A (de) 1968-04-22
DE1617775B1 (de) 1970-10-22
DK121619B (da) 1971-11-08
FI43625B (de) 1971-02-01

Similar Documents

Publication Publication Date Title
Vesikari et al. Protection of infants against rotavirus diarrhoea by RIT 4237 attenuated bovine rotavirus strain vaccine
Bradburne et al. Coronavirus antibody titres in sera of healthy adults and experimentally infected volunteers
Sever et al. Rubella virus.
Wood et al. Chronic enteric virus infection in two T‐cell immunodeficient children
Asano et al. Five-year follow-up study of recipients of live varicella vaccine using enhanced neutralization and fluorescent antibody membrane antigen assays
US3959466A (en) Highly attenuated cytomegalovirus vaccine and production thereof
Horstmann et al. Epidemiology of rubella: subclinical infection and occurrence of reinfection
JPS58146513A (ja) 鳥感染性気管支炎ワクチン
Donelli et al. A three-year diagnostic and epidemiological study on viral infantile diarrhoea in Rome
NO170199B (no) Fremgangsmaate for loesbar fastgjoering av et siktelement i en holder i et vibrasjonssikteapparat, og vibrasjons-sikteapparat som et slikt siktelement kan monteres i
US3354038A (en) Serial passaging tissue cultured canine distemper virus to form attenuated vaccine short of virus-antigenicity decreasing passages
Ross et al. Problems of laboratory diagnosis of respiratory syncytial virus infection in childhood
JPH05509225A (ja) Ｃ型ロタウイルス培養体およびその利用法
SELL et al. Some observations on acute bronchiolitis in infants
Miura et al. A survey of antibodies to arthropod-borne viruses in Japanese cattle
White et al. Prevalence of antibody to poliovirus in England and Wales 1984-6.
KILLGORE et al. Antigenic characterization of parainfluenza 4A and 4B by the hemagglutination-inhibition test and distribution of HI antibody in human sera
US3897549A (en) Herpes simplex type 2 virus vaccine and method of production and use
Scott et al. Respiratory syncytial virus neutralizing activity in nasopharyngeal secretions
EP0133200A1 (de) Diagnostisches Antigen für Träger der durch Pseudorabiesviren verursachten Krankheit bei Schweinen
US3686394A (en) Attenuated live rubella virus vaccine and method of production
Potter et al. Interference following dual inoculation with influenza A (H3N2) and (H1N1) viruses in ferrets and volunteers
Smith A localized outbreak of dengue fever in Kuala Lumpur: serological aspects
Parker Immunological studies of a heat-stable substance isolated from tissues infected with vaccine virus
Ruben et al. Humoral and secretory antibody responses to immunization with low and high dosage split influenza virus vaccine